Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter

Sales rise 14.08% to Rs 1353.73 crore

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1353.73	1186.64	14
OPM %	24.22	26.22	-
PBDT	383.78	324.63	18
PBT	340.81	290.24	17
NP	260.19	216.48	20

Powered by Capital Market - Live News